FDA Clarifies: You Cannot Compound Approved Drugs

Last year, during the drug pricing debate triggered by Turing Pharma’s Martin Shkreli, a San Diego compounding pharmacy Imprimis Pharmaceuticals announced that it would offer a cheap compounded version of the expensive FDA-approved drug. At that time, we criticized Imprimis based on our belief that such a practice will jeopardize all approved drugs. This week FDA confirmed … Read more